Academic Journal
View in EDS
PDF Full Text
HTML Full Text

A pilot study of measuring emotional response and perception of LLM-generated questionnaire and human-generated questionnaires

Bibliographic Details
Title: A pilot study of measuring emotional response and perception of LLM-generated questionnaire and human-generated questionnaires
Authors: Zhao Zou, Omar Mubin, Fady Alnajjar, Luqman Ali
Source: Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Publisher Information: Nature Portfolio, 2024.
Publication Year: 2024
Collection: LCC:Medicine
LCC:Science
Subject Terms: Medicine, Science
More Details: Abstract The advent of ChatGPT has sparked a heated debate surrounding natural language processing technology and AI-powered chatbots, leading to extensive research and applications across various disciplines. This pilot study aims to investigate the impact of ChatGPT on users' experiences by administering two distinct questionnaires, one generated by humans and the other by ChatGPT, along with an Emotion Detecting Model. A total of 14 participants (7 female and 7 male) aged between 18 and 35 years were recruited, resulting in the collection of 8672 ChatGPT-associated data points and 8797 human-associated data points. Data analysis was conducted using Analysis of Variance (ANOVA). The results indicate that the utilization of ChatGPT enhances participants' happiness levels and reduces their sadness levels. While no significant gender influences were observed, variations were found about specific emotions. It is important to note that the limited sample size, narrow age range, and potential cultural impacts restrict the generalizability of the findings to a broader population. Future research directions should explore the impact of incorporating additional language models or chatbots on user emotions, particularly among specific age groups such as older individuals and teenagers. As one of the pioneering works evaluating the human perception of ChatGPT text and communication, it is noteworthy that ChatGPT received positive evaluations and demonstrated effectiveness in generating extensive questionnaires.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-2322
Relation: https://doaj.org/toc/2045-2322
DOI: 10.1038/s41598-024-53255-1
Access URL: https://doaj.org/article/d4518c76740446ccb484f76a34505db3
Accession Number: edsdoj.4518c76740446ccb484f76a34505db3
Database: Directory of Open Access Journals
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
    Url: https://content.ebscohost.com/cds/retrieve?content=AQICAHjPtM4BHU3ZchRwgzYmadcigk49r9CVlbU7V5F6lgH7WwFDYSSl8mIQIQAv4Gz4MBlfAAAA4jCB3wYJKoZIhvcNAQcGoIHRMIHOAgEAMIHIBgkqhkiG9w0BBwEwHgYJYIZIAWUDBAEuMBEEDGG639RJigTuRhQPWwIBEICBmgX8CVaEL2WmAtnrQRnaYSmg77MTbSBLYcF5E19uFx8HCpzFi51H_VTUZ0TI79H2OvS_jonl6bs6FypKPNto_YKDWCQIsWJqkah8ks0n6ZPymsfj4O33kuqCDLG6zQ03DnTZ1uvCg7kVi5gqaQIbQBIjfSlKFSmo0kPPHx_phc-cmYo9ySxOeevfOGkoVZrDctTd_CBJGzAq9JQ=
Text:
  Availability: 1
  Value: <anid>AN0178149113;[fkqs]27jun.24;2024Jul02.05:31;v2.2.500</anid> <title id="AN0178149113-1">Causal role of immune cells on cervical cancer onset revealed by two-sample Mendelian randomization study </title> <p>Cervical cancer (CC) is a prevalent gynecological cancer worldwide that significantly impacts the quality of life and the physical and mental well-being of women. However, there have been limited studies utilizing Mendelian randomization (MR) analysis to investigate the connection between immune cells and CC. This study is to investigate the causal effects of immune traits on CC and non-neoplastic conditions of the cervix. The GWAS data for 731 immunophenotypes and six GWAS data for CC from the FinnGen database were downloaded. Subsequently, a two-sample MR analysis was conducted using the MR Egger, Weighted median, Inverse variance weighted (IVW), Simple mode, and Weighted mode methods. Our study has identified the potential causal effects of immune traits on inflammatory diseases of the cervix, other noninflammatory disorders of the cervix uteri, carcinoma in situ of cervix uteri, adenocarcinomas of cervix, squamous cell neoplasms and carcinoma of cervix, as well as malignant neoplasm of the cervix uteri, with the respective numbers being 8, 6, 11, 8, 23, and 12, respectively. A strong correlation between classic monocytes and various cervical diseases was revealed. Furthermore, we discovered that B cells expressing BAFF-R have the ability to impede the advancement of malignant CC, specifically squamous cell neoplasms and carcinoma of cervix. Our study has demonstrated a significant association between immune traits and both CC and non-neoplastic conditions of the cervix through two-sample Mendelian randomization, providing valuable insights for future clinical research.</p> <p>Keywords: Cervical cancer; Cervical non-neoplastic conditions; Immune traits; Two-sample Mendelian randomization analysis; Causal effects</p> <p>These authors contributed equally: Zicheng Zhao and Pengxian Yan.</p> <hd id="AN0178149113-2">Introduction</hd> <p>Cervical cancer (CC) is widely recognized as a significant public health issue and holds the position of being the fourth deadliest form of cancer among women across the globe[<reflink idref="bib1" id="ref1">1</reflink>],[<reflink idref="bib2" id="ref2">2</reflink>]. According to WHO data, approximately 604,000 new cases were diagnosed globally in 2020[<reflink idref="bib3" id="ref3">3</reflink>]. CC, especially in developing countries, is identified as the primary cause of death for women worldwide, as stated by the International Agency for Research on Cancer[<reflink idref="bib2" id="ref4">2</reflink>]. While most women with early-stage tumors can receive treatment, many experience long-term complications. Chemoradiation (CAT) is the recommended treatment for locally advanced CC[<reflink idref="bib4" id="ref5">4</reflink>],[<reflink idref="bib5" id="ref6">5</reflink>]. The timing of CAT plays a crucial role in determining survival outcomes, and its efficacy in underdeveloped nations remains uncertain due to the absence of suitable screening techniques[<reflink idref="bib6" id="ref7">6</reflink>],[<reflink idref="bib7" id="ref8">7</reflink>].</p> <p>Numerous factors, such as smoking, a compromised immune system, and prolonged use of oral contraceptives, contribute to the development of CC[<reflink idref="bib8" id="ref9">8</reflink>]. The primary cause of CC is a persistent infection with high-risk types of the human papillomavirus (HPV), particularly HPV16 and/or HPV18, which are the most common culprits[<reflink idref="bib9" id="ref10">9</reflink>]. Therefore, further exploration of these HPV types may uncover causes that are linked either directly or indirectly to other malignancies in the human reproductive system. It is well-documented that the tumor microenvironment (TME) plays crucial roles in the occurrence and progression of tumors. In the case of CC, both innate and acquired immune responses are present in HPV-infected lesions[<reflink idref="bib10" id="ref11">10</reflink>]. For instance, cell migration to the squamous epidermis, particularly T lymphocytes and Langerhans cells, occurs in response to high-risk HPV infection[<reflink idref="bib11" id="ref12">11</reflink>]. The regression or progression of CC depends on the interaction of various cellular immune responses[<reflink idref="bib12" id="ref13">12</reflink>].</p> <p>Mendelian randomization (MR) is an analytical method that infers the causal effects of exposure on outcomes using genetic variations in non-experimental data. Since alleles are randomly assigned during meiosis, MR can minimize traditional confounding variables and reverse causality, thereby providing stronger evidence for causal inference[<reflink idref="bib13" id="ref14">13</reflink>]. MR utilizes existing GWAS data to address some limitations and issues encountered in traditional observational studies and randomized controlled trials. When using MR as a research method, three assumptions must be met: (<reflink idref="bib1" id="ref15">1</reflink>) genetic variation must be associated with the exposure factor; (<reflink idref="bib2" id="ref16">2</reflink>) genetic variation must affect the outcome through exposure, rather than through other factors; (<reflink idref="bib3" id="ref17">3</reflink>) genetic variation is not associated with any known or unknown confounding factors related to the outcome. In general, these three key assumptions must be satisfied to ensure the validity of the analysis. Violating any one of them will introduce bias to any causal inference[<reflink idref="bib13" id="ref18">13</reflink>],[<reflink idref="bib14" id="ref19">14</reflink>]. In conclusion, although MR cannot entirely confirm causal relationships, it can to a large extent provide evidence for causal relationships. The development of CC is hindered by immune cells, and within the TME, there are specific subsets of immune cells that "suppress" tumor immunity, leading to a more intricate tumor microenvironment for CC[<reflink idref="bib15" id="ref20">15</reflink>],[<reflink idref="bib16" id="ref21">16</reflink>]. Currently, there is a lack of extensive research samples that investigate the link between immune inflammation and CC. In this study, a comprehensive two-sample MR analysis was conducted to determine the causal relationship between immune cell characteristics and different types of CC and cervical non-neoplastic conditions (inflammatory diseases of the cervix and other noninflammatory disorders of the cervix uteri).</p> <hd id="AN0178149113-3">Methods</hd> <p></p> <hd id="AN0178149113-4">Genome-wide association study (GWAS) data sources of 731 immune traits</hd> <p>Publicly available GWAS data of 731 immunophenotypes were downloaded from GWAS Catalog (accession number: GCST0001391-GCST0002121) as described previously[<reflink idref="bib17" id="ref22">17</reflink>],[<reflink idref="bib18" id="ref23">18</reflink>]. Briefly, these 731 types of immune traits are divided into four main categories, namely absolute cell (n = 118), relative cell counts (n = 192), morphological parameters (n = 32), and median fluorescence intensities (n = 389). This dataset contains the detailed information of approximately 22 million SNPs genotyped using high-density arrays in 3,757 European individuals, as recorded by Sidore et al.[<reflink idref="bib19" id="ref24">19</reflink>]. Detailed information of the immune traits was described previously[<reflink idref="bib19" id="ref25">19</reflink>],[<reflink idref="bib20" id="ref26">20</reflink>].</p> <hd id="AN0178149113-5">GWAS data sources of various types of CC and cervical non-neoplastic conditions</hd> <p>The GWAS statistical data of various types of CC and cervical non-neoplastic conditions used in this study were obtained from FinnGen Research (https://risteys.finregistry.fi/), including data on inflammatory diseases of the cervix (N14_INFCERVIX, 2009 cases and 205,362 controls), other noninflammatory disorders of cervix uteri (N14_OTHNONINFCERVIX, 1512 cases and 111,583 controls), carcinoma in situ of cervix uteri [CD2_INSITU_CERVIX_UTERI_EXALLC, cervical intraepithelial neoplasia (CIN) III, 2458 cases and 180,963 controls], adenocarcinomas of cervix (C3_CERVIX_ADENO_EXALLC, 116 cases and 182,927 controls), squamous cell neoplasms and carcinoma of cervix (SCNCC, C3_CERVIX_SQUAM_EXALLC, 168 cases and 182,927 controls), and malignant neoplasm of cervix uteri (C3_CERVIX_UTERI_EXALLC, 388 cases and 182,927 controls). Samples starting with C3 represent malignant samples, those starting with CD2 represent benign in situ carcinoma, and N14 represent non-cancerous samples. These six data contained a total of 687,486 samples. The detailed information of GWAS data for CC and cervical non-neoplastic conditions used in this study is shown in Supplementary Tables 1 and 2. Each dataset was initially used as outcome data for the two-sample Mendelian randomization analysis and used as exposures during reverse two-sample MR analysis. After quality control and imputation, approximately 12,132 million variants were analyzed, identifying a total of 1,066 independent single nucleotide polymorphisms (SNPs).</p> <hd id="AN0178149113-6">Instrumental variables (IV) selection</hd> <p>The significance level of each IV related to immune traits was set to 1 × 10<sups>–5</sups> according to the common standards[<reflink idref="bib3" id="ref27">3</reflink>],[<reflink idref="bib17" id="ref28">17</reflink>],[<reflink idref="bib18" id="ref29">18</reflink>]. In order to ensure the reliability of the results and prevent bias caused by strong linkage disequilibrium (LD) between SNPs, a threshold of r<sups>2</sups> < 0.001 was implemented to account for LD effects, with LD regions limited to 10,000 kb[<reflink idref="bib18" id="ref30">18</reflink>],[<reflink idref="bib21" id="ref31">21</reflink>]. To evaluate the strength of each IV and avoid weak instrument bias, the proportion of phenotypic variance explained (PVE) and the F-statistic were calculated. IVs with an F-statistic below 10 were excluded, while those remaining were designated as strong IVs for further analysis.</p> <hd id="AN0178149113-7">Two-sample MR analysis</hd> <p>To investigate the causal relationship between immunophenotypes and the onset of CC, we utilized the TwoSampleMR R software package (version 0.5.8) to conduct two-sample MR analysis in the R software (https://<ulink href="http://www.r-project.org/,">www.r-project.org/,</ulink> version 4.2.3). MR Egger[<reflink idref="bib22" id="ref32">22</reflink>], Weighted median[<reflink idref="bib23" id="ref33">23</reflink>], Inverse variance weighted (IVW)[<reflink idref="bib24" id="ref34">24</reflink>], Simple mode, and Weighted mode were used for two-sample MR analysis. A positive overall result is determined when the IVW method, along with at least one of the MR Egger, Weighted Median, Simple Mode, or Weighted Mode methods, yield positive outcomes for each analysis. In order to minimize the impact of CC on immune traits, a reverse MR analysis was performed on immunophenotypes that demonstrate a strong association with CC or cervical non-neoplastic conditions.</p> <hd id="AN0178149113-8">Statistical analysis</hd> <p>In the random effects model, IVW was used as the main analytical method. The MR results were derived from the SNPs that were screened below the genome-wide significance threshold (p < 5 × 10<sups>−8</sups>). After obtaining the MR results, sensitivity analyses were conducted, such as heterogeneity testing and multiple-effect testing using the MR Egger method and MR-PRESSO test. The MR Egger method is utilized for the initial identification of horizontal pleiotropy[<reflink idref="bib22" id="ref35">22</reflink>]. If the p-value is below 0.05, it signifies the presence of horizontal pleiotropy. The MR-PRESSO outlier test assesses the existence of specific horizontal pleiotropy outlier IVs by contrasting the observed and expected distribution of the test IVs[<reflink idref="bib25" id="ref36">25</reflink>]. In comparison to MR Egger, the MR-PRESSO test can more precisely detect biased SNPs[<reflink idref="bib25" id="ref37">25</reflink>]. If the p-value is less than 0.05, indicating the presence of a biased SNP, it should be excluded from the IVs; if the p-value is above 0.05, it suggests the absence of a biased SNP. For sensitivity analysis and calculating the remaining cumulative effects of the SNPs, the leave-one-out approach was utilized. To assess if IVs influenced the outcomes through other pathways than exposure, horizontal pleiotropy tests were conducted using the intercept terms derived from the MR-Egger regression[<reflink idref="bib25" id="ref38">25</reflink>]. The risk of CC and cervical non-neoplastic conditions in relation to the immune traits was summarized using odds ratios (ORs) and 95% confidence intervals (95% CIs). Subsequently, a criterion of p-values less than 0.05 was used to screen for immune traits associated with CC. Considering reverse MR analysis, results with a p-value of higher than 0.05 were kept.</p> <hd id="AN0178149113-9">Results</hd> <p></p> <hd id="AN0178149113-10">Causal effect of immune traits on cervical non-neoplastic conditions</hd> <p>To investigate the potential causal effect of immunophenotypes on the onset of CC, a two-sample MR analysis was conducted using GWAS data from 731 immune cells and six datasets comprising different statuses of CC and non-neoplastic samples. We first conducted analyses on two non-neoplastic conditions, namely inflammatory diseases of the cervix and other noninflammatory disorders of the cervix uteri. Following the filtering process, two traits (CCR2 on monocytes and CD11c on monocytes) demonstrated a positive association with inflammatory diseases of the cervix (Fig. 1). Meanwhile, six immune traits [CD3 on CD39+ resting Treg, CD25 on CD20−CD38− (B cell), CD25hi CD45RA+ CD4 not Treg AC, CD62L on CD62L+ DC, CD62L on CD62L+ myeloid DC, and Unsw Mem %lymphocyte (B cell)] displayed potential protective effects against inflammatory diseases of the cervix. The results of MR Egger, Weighted median, IVW, Simple mode, and Weighted mode tests showed a consistent direction, indicating the reliability of the results. Supplementary Fig. 1 illustrated the scatter plots displaying the impact of immune traits on inflammatory diseases of the cervix. In order to ensure the reliability of our results, reverse MR analysis was conducted to examine potential reverse causation using immune traits that displaying a strong association with inflammatory diseases of the cervix. The results showed that there was no evidence of a causal connection between inflammatory diseases of the cervix and immune traits. To summarize, our study identified a causal relationship between specific immunophenotypes and the incidence of inflammatory diseases of the cervix. For the data on other noninflammatory disorders of the cervix uteri, it was found that CCR2 on CD14−CD16− (monocyte) was nominally associated with an increased risk of these disorders. However, BAFF-R on CD20- (B cell), CD3 on activated Treg, CD3 on CD39+ activated Treg, CD25 on B cell, and CD45 on NK showed significant protective effects against cervix disorders (Fig. 2). The scatter plots indicated the stability of the results in Supplementary Fig. 2. Reverse MR analysis did not reveal any evidence of a causal connection between other noninflammatory disorders of the cervix uteri and immune traits. In conclusion, monocytes have been found to have a positive causal correlation with non-neoplastic diseases of the cervix, such as inflammatory conditions and other disorders of the cervix uteri.</p> <p>Graph: Figure 1 Forest plots showed the causal associations between immune cell traits and inflammatory diseases of the cervix.</p> <p>Graph: Figure 2 Forest plot to visualize the causal effects of immune cell traits and other noninflammatory disorders of cervix uteri.</p> <hd id="AN0178149113-11">Causal effect of immune traits on carcinoma in situ of cervix uteri</hd> <p>We then conducted an analysis of the causal effect of immune traits on carcinoma in situ of the cervix uteri. Finally, 12 types of four major categories of immune cells were found to be related to the in situ GWAS data (Fig. 3). Apart from CD38 on IgD- CD38dim and HLA DR on B cell were B cell lymphocyte, the remaining cells were all different types of T cells. Among these 12 types of immune cells, one type (HLA DR on B cells) exhibited a negative causal estimate towards in situ of cervix uteri, with IVW OR 0.911 (0.833 to 0.996, 0.041). On the other hand, the remaining types (CD25 on secreting Treg, CD3 on activated & secreting Treg, CD3 on CD28+ CD45RA−CD8br, CD3 on CD39+ CD4+, CD3 on CD4 Treg, CD3 on CD45RA+ CD4+, CD3 on CM CD8br, CD3 on secreting Treg, CD38 on IgD − CD38dim, CD8dim %T cell, Naive DN (CD4 − CD8 −) AC) showed a positive correlation with the onset of in situ of cervix uteri, with IVW OR(95% CI, P) of 1.059 (1.016 to 1.103, 0.006), 1.063 (1.005 to 1.124, 0.032), 1.150 (1.063 to 1.245, 0.001), 1.055 (1.004 to 1.108, 0.034), 1.09 (1.009 to 1.178, 0.028), 1.064 (1.015 to 1.115, 0.01), 1.089 (1.000 to 1.185, 0.049), 1.085 (1.025 to 1.148, 0.005), 1.050 (1.006 to 1.095, 0.027), 1.117 (1.014 to 1.231, 0.025), and 1.118 (1.011 to 1.235, 0.029). The alignment between IVW and other four MR techniques was evident in most MR analyses (Supplementary Fig. 3). Notably, the p value of the MR-PRESSO test for HLA DR on B cell was less than 0.001, indicating the presence of horizontal heterogeneity between exposure factors and outcome variables. Furthermore, reverse MR analysis revealed evidence of a causal relationship between in situ of the cervix uteri and HLA DR on B cells. As a result, HLA DR on B cells was eliminated from consideration. Collectively, 11 types of immune traits were demonstrated to exert a causal effect on carcinoma in situ of the cervix uteri.</p> <p>Graph: Figure 3 Causal effects to display the immune cell traits and carcinoma in situ of cervix uteri illustrated by forest plot.</p> <hd id="AN0178149113-12">Causal effect of immune traits on malignant CC</hd> <p>To investigate the causal effect of immune traits on malignant CC, a two-sample MR analysis was performed using GWAS data of adenocarcinomas of cervix, SCNCC, and malignant neoplasm of cervix uteri as outcome variables. For adenocarcinomas of cervix, eight immune traits belonging to three cell types (B cell, T cell, and monocyte) were identified (Fig. 4). Among the identified cell subtypes, four types of immune traits were positively correlated with adenocarcinomas of cervix, while the other four immunophenotypes were negatively correlated with the disease. It is worth noting that different subtypes of the same class of cells surprisingly play varying roles in the onset of diseases. B cell subsets BAFF-R on IgD+ CD38− naive, CD24 on unsw mem, and CD38 on CD20− were positively associated with the occurrence of adenocarcinomas of cervix, whereas CD20− %B cells exhibited a protective effect against the disease. Similarly, Monocyte AC showed a positive correlation with adenocarcinomas of cervix, while CD64 on CD14+ CD16+ monocytes had a negative causal effect on adenocarcinomas of the cervix. This result indicates that in-depth study of cell typing is of crucial significance for understanding the occurrence and development of CC. There was no evidence of a causal relationship between adenocarcinomas of cervix and the eight immune traits in the reverse MR analysis. Supplementary Tables 3, 4 and 5 provided a comprehensive overview of the detailed findings. In summary, a causal relationship between adenocarcinomas of the cervix and the eight immune traits was identified.</p> <p>Graph: Figure 4 Forest plot showing the causal effects of immune cell traits and adenocarcinomas of cervix.</p> <p>Considering SCNCC, a total of 23 immune traits were found to be associated with the disease (Fig. 5). Most of these immunophenotypes were identified as protective factors, while only four showed a positive correlation with the onset of the disease. Out of the 23 identified subtypes of immune cells, 14 are B cells, and 13 of these cells express BAFF-R (B-cell activating factor receptor). Therefore, the expression of BAFF-R may have a protective effect on the development of squamous CC. Different subtypes of T cells exert different functions, but regulatory T cells exhibit a protective effect. Like adenocarcinomas of cervix and non-neoplastic diseases, monocytes (CD11c+ HLA DR++ monocyte AC) showed a positive correlation trend with disease progression. In the reverse MR analysis, no evidence was found to suggest a causal relationship between SCNCC and the 23 immune traits. Supplementary Tables 6, 7 and 8 presented a detailed summary of the findings.</p> <p>Graph: Figure 5 Forest plot revealed the causal effects of immune cell traits and squamous cell neoplasms and carcinoma of cervix.</p> <p>In cases of malignant neoplasm of the cervix uteri, a total of 12 immune traits were screened (Fig. 6). Supplementary Tables 9, 10 and 11 demonstrated a detailed summary of the findings. Nine were B cell and three were T cell, all of which were found to have a negative association with the onset of the disease. Similar to SCNCC, the B cell was BAFF-R positive. Among these eight B cell subtypes, except for BAFF-R on IgD− CD38−, the others were identified as disease-relevant factors in SCNCC. Furthermore, BAFF-R on IgD + CD38− and BAFF-R on IgD− CD38− only differ in IgD expression, but both have been identified as having a causal relationship with malignant neoplasm of the cervix uteri. This result further emphasizes the importance of BAFF-R in the development of malignant CC. The three T cells expressed HVEM (Herpesvirus entry mediator), with HVEM on CM CD4+ and HVEM on EM CD4+ belonging to HVEM on CD45RA−CD4+. No evidence was found in the reverse MR analysis to suggest a causal relationship between malignant neoplasm of the cervix uteri and the 12 immune traits. Collectively, a causal effect of immune traits was identified in three types of malignant CC, namely adenocarcinomas of cervix, SCNCC, and malignant neoplasm of cervix uteri.</p> <p>Graph: Figure 6 Forest plot to depict the causal effects of immune cell traits and malignant neoplasm of cervix uteri.</p> <hd id="AN0178149113-13">Discussion</hd> <p>TME plays a crucial role in cancer initiation and progression, with T cells, B cells, NK cells, stromal cells, NKT cells, and fibroblasts being the main components of TME. Therefore, research on the composition of immune cells in the TME is vital for understanding tumor onset and development. In this study, four types of immune traits were found to be associated with the onset of inflammatory diseases of the cervix: B cells, T cells, cDCs, and monocytes. Specifically, CCR2 on monocytes and CD11c on monocytes were identified as potential factors increasing the risk of inflammatory diseases of the cervix. These traits characterize classical monocytes known for their proinflammatory nature and high production of various inflammatory factors. Additionally, CD11c, a member of the integrin family, facilitates cell migration during inflammatory responses. We also found that CCR2 on CD14−CD16− (Monocyte panel) was linked to a higher likelihood of developing cervical disorders. CCR2 (C–C motif chemokine receptor 2) is expressed on classical monocytes and interacts with CCL2 to facilitate the migration of monocytes[<reflink idref="bib26" id="ref39">26</reflink>],[<reflink idref="bib27" id="ref40">27</reflink>]. Classical monocytes exhibit a proinflammatory nature and generate the highest amounts of CCL2, granulocyte colony-stimulating factor (CSF), and IL-6/10[<reflink idref="bib28" id="ref41">28</reflink>]. Additionally, they release high levels of reactive oxygen species (ROS) and show the highest production of CCL2/3 and IL-8/10 when stimulated with lipopolysaccharide (LPS)[<reflink idref="bib29" id="ref42">29</reflink>]. During inflammatory responses, cell migration is facilitated by CD11c, a member of the integrin family, through cell–cell adhesion[<reflink idref="bib30" id="ref43">30</reflink>]. With other noninflammatory disorders of the cervix uteri, CCR2 on CD14−CD16− (monocyte panel) was linked to a higher likelihood of developing cervical disorders. Combining our analysis results with the experimental results of previous researchers, we believe that classic monocytes may play an important role in the non-neoplastic conditions of CC through their pro-inflammatory effects. In the other immune cell phenotypes we identified, aside from CD45 on NK cells, all others were specific immune cells, indicating a potential role of acquired immunity in inhibiting the progression of diseases.</p> <p>For adenocarcinomas of cervix, the absolute count of monocytes was found to be positively correlated with the disease. However, the presence of CD64 on CD14+ CD16+ monocytes was identified as having a negative causal effect. In humans, three primary subsets of monocytes have been recognized: classical (CD14+ CD16−), intermediate (CD14+ CD16+), and nonclassical (CD14−CD16+−)[<reflink idref="bib31" id="ref44">31</reflink>]. These subsets exhibit functional variances, including their responses to inflammation and ability to migrate[<reflink idref="bib32" id="ref45">32</reflink>]. Intermediate monocytes exhibit elevated levels of HLA-DR, CD80, CD86, and TNFR1, suggesting their involvement in both antigen presentation and inflammatory functions[<reflink idref="bib33" id="ref46">33</reflink>]. In addition, intermediate monocytes demonstrate genes that oversee chemotaxis and angiogenesis (AIF1 and TIE2) as well as phagocytosis and tissue repair (TGFB and CD93)[<reflink idref="bib34" id="ref47">34</reflink>]. This suggests that intermediate monocytes, despite being considered inflammatory, are also likely participating in anti-inflammatory processes[<reflink idref="bib35" id="ref48">35</reflink>]. We believe that CD64 on CD14+ CD16+ monocytes plays an important anti-inflammatory role in the pathogenesis of adenocarcinomas of the cervix, showing a negative correlation with disease progression. The percentage of CD20- in B cell was negatively associated with adenocarcinomas of cervix, however, CD38 on CD20- (B cell) was a risk factor for disease progression. Consequently, further research is necessary to deepen our understanding of the relationship between the classification of immune cells and adenocarcinomas of the cervix.</p> <p>Compared with other types of cervical diseases, SCNCC present with more disease-related factors. Specifically, CD11c+ HLA DR++ monocyte AC was positively correlated with disease progression in these conditions. Almost all of the 14 identified B cell types that offer protective effects against the disease express BAFF-R. BAFF, also known as CD257, TNFSF13B, and BLyS, belongs to the tumor necrosis factor (TNF) family. It binds specifically to BAFF-R (TNFRSF13C) and plays a critical role in regulating B-cell functions and autoimmune diseases like systemic lupus erythematosus (SLE) and blood cancers[<reflink idref="bib36" id="ref49">36</reflink>]. B-cell subsets exhibit varying levels of expression of BAFF system receptors[<reflink idref="bib37" id="ref50">37</reflink>]. BAFF promotes B-cell growth and survival both in vitro and in vivo by enhancing protein levels and activating genes linked to glucose uptake and glycolytic metabolism, leading to B-cell hyperactivity in response to mitogenic stimulation during inflammation[<reflink idref="bib38" id="ref51">38</reflink>]. Based on our analysis and previous studies, we believe that the expression of BAFF-R in B cells plays a crucial protective role in the progress of SCNCC. Similarly, BAFF-R positive B cells are beneficial in the advancement of malignant neoplasm of the cervix uteri, indicating the significance of BAFF-R.</p> <p>In pre-cancerous lesions and malignant cervical cancer, acquired immune cells typically play a protective role in the development of the disease. However, in the in situ of cervix uteri, T cells and B cells have been identified as being associated with the progression of the disease, with all cells playing a promotive role in its development. This analysis result has significant contradictions with our perception. There was a widespread agreement on the important role of effector T cells in antitumour responses[<reflink idref="bib39" id="ref52">39</reflink>]. Tumors can be categorized based on how cytotoxic immune cells are dispersed within the tumor microenvironment (TME) into immune-inflamed, immune-excluded, and immune-desert phenotypes. Based on the dispersion of cytotoxic immune cells within the TME, a tumor can be classified into one of three primary immunophenotypes: immune-inflamed, immune-excluded, and immune-desert phenotypes[<reflink idref="bib40" id="ref53">40</reflink>]. Immune-inflamed tumors, also known as "hot tumors", are characterized by high levels of T-cell infiltration, increased interferon-y (IFN-y) signaling, and a high tumor mutational burden (TMB)[<reflink idref="bib41" id="ref54">41</reflink>]. Conversely, immune-excluded and immune-desert tumors are commonly known as 'cold tumors'[<reflink idref="bib42" id="ref55">42</reflink>],[<reflink idref="bib43" id="ref56">43</reflink>]. In immune-excluded tumors, CD8+ T lymphocytes are limited to the edges of the tumor invasion and do not effectively penetrate the tumor[<reflink idref="bib43" id="ref57">43</reflink>]. Therefore, we suspect that in the case of cervix uteri, it may exhibit characteristics of immune-excluded tumors. Despite having a large number of T cells, they do not infiltrate the tumor tissues effectively, indicating a positive correlation between the T cell phenotype and the disease.</p> <p>In conclusion, this study involved the analysis of GWAS data for 731 immune traits and six GWAS data sets for CC and cervical non-cancer cases. Two-sample MR analysis was conducted to determine the causal role of immune cells in the onset of CC. Our findings revealed a positive correlation between classic monocytes and various cervical diseases. Additionally, we observed that B cells expressing BAFF-R have an inhibitory effect on malignant CC, specifically SCNCC. The results of our analysis provide valuable insights into the pathogenesis of cervical diseases and offer potential implications for the clinical treatment of cervical cancer through immune cell subtyping.</p> <hd id="AN0178149113-14">Conclusion</hd> <p>In conclusion, this study involved the analysis of GWAS data for 731 immune traits and six GWAS data sets for CC and non-cancer cases. Two-sample MR analysis was conducted to determine the causal role of immune cells in the onset of CC. Our findings revealed a positive correlation between classic monocytes and various cervical diseases. Additionally, we observed that B cells expressing BAFF-R have a inhibitory effect on malignant cervical cancer, specifically SCNCC. Our analysis yields valuable insights into the pathogenesis of cervical diseases, revealing a correlation between local immune status and cervical lesions through analysis integrated with GWAS.</p> <hd id="AN0178149113-15">Author contributions</hd> <p>ZZ designed the study, performed data analysis, and wrote the first draft of the manuscript. YP, ZX, YX, LF, and GM participated in data collation. Y XA designed the study, analyzed data, and wrote the manuscript. All authors have read and approved the final version of the manuscript.</p> <hd id="AN0178149113-16">Funding</hd> <p>This work was supported by Natural Science Foundation of Hebei Province (H2020406049) and Initial Scientific Research Fund for High-Level Talents of Chengde Medical University (201901).</p> <hd id="AN0178149113-17">Data availability</hd> <p>The data utilized in this study were obtained from the GWAS platform (https://gwas.mrcieu.ac.uk/) and the FinnGen Research (https://risteys.finregistry.fi/), both of which are freely accessible.</p> <hd id="AN0178149113-18">Competing interests</hd> <p>The authors declare no competing interests.</p> <hd id="AN0178149113-19">Supplementary Information</hd> <p>Graph: Supplementary Figure 1.</p> <p>Graph: Supplementary Figure 2.</p> <p>Graph: Supplementary Figure 3.</p> <p>Graph: Supplementary Table 1.</p> <p>Graph: Supplementary Table 2.</p> <p>Graph: Supplementary Table 3.</p> <p>Graph: Supplementary Table 4.</p> <p>Graph: Supplementary Table 5.</p> <p>Graph: Supplementary Table 6.</p> <p>Graph: Supplementary Table 7.</p> <p>Graph: Supplementary Table 8.</p> <p>Graph: Supplementary Table 9.</p> <p>Graph: Supplementary Table 10.</p> <p>Graph: Supplementary Table 11.</p> <hd id="AN0178149113-20">Supplementary Information</hd> <p>The online version contains supplementary material available at https://doi.org/10.1038/s41598-024-65957-7.</p> <hd id="AN0178149113-21">Publisher's note</hd> <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p> <ref id="AN0178149113-22"> <title> References </title> <blist> <bibl id="bib1" idref="ref1" type="bt">1</bibl> <bibtext> Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019; 393: 169-182. 30638582. 10.1016/S0140-6736(18)32470-X</bibtext> </blist> <blist> <bibl id="bib2" idref="ref2" type="bt">2</bibl> <bibtext> Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob. Health. 2020; 8: e191-e203. 31812369. 10.1016/S2214-109X(19)30482-6</bibtext> </blist> <blist> <bibl id="bib3" idref="ref3" type="bt">3</bibl> <bibtext> Yu XH, Yang YQ, Cao RR, Bo L, Lei SF. The causal role of gut microbiota in development of osteoarthritis. Osteoarthritis Cartil. 2021; 29: 1741-1750. 10.1016/j.joca.2021.08.003</bibtext> </blist> <blist> <bibl id="bib4" idref="ref5" type="bt">4</bibl> <bibtext> Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 1999; 340: 1137-1143. 1:STN:280:DyaK1M3gtVOntg%3D%3D. 10202164. 10.1056/NEJM199904153401501</bibtext> </blist> <blist> <bibl id="bib5" idref="ref6" type="bt">5</bibl> <bibtext> Stehman FB, Ali S, Keys HM, Muderspach LI, Chafe WE, Gallup DG, Walker JL, Gersell D. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: Follow-up of a Gynecologic Oncology Group trial. Am. J. Obstet. Gynecol. 2007; 197; 503: e501-506</bibtext> </blist> <blist> <bibl id="bib6" idref="ref7" type="bt">6</bibl> <bibtext> Garcia E, Ayoub N, Tewari KS. Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer. J. Gynecol. Oncol. 2024; 35. 1:CAS:528:DC%2BB2cXhtFyqu7%2FN. 38072400. 10.3802/jgo.2024.35.e30</bibtext> </blist> <blist> <bibl id="bib7" idref="ref8" type="bt">7</bibl> <bibtext> Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Benard E, Boily MC, Sy S, Regan C, Keane A, Caruana M, Nguyen DTN, Smith MA, Laprise JF, Jit M, Alary M, Bray F, Fidarova E, Elsheikh F, Bloem PJN, Broutet N, Hutubessy R. Impact of HPV vaccination and cervical screening on cervical cancer elimination: A comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020; 395: 575-590. 32007141. 7043009. 10.1016/S0140-6736(20)30068-4</bibtext> </blist> <blist> <bibl id="bib8" idref="ref9" type="bt">8</bibl> <bibtext> Johnson CA, James D, Marzan A, Armaos M. Cervical cancer: An overview of pathophysiology and management. Semin. Oncol. Nurs. 2019; 35: 166-174. 30878194. 10.1016/j.soncn.2019.02.003</bibtext> </blist> <blist> <bibl id="bib9" idref="ref10" type="bt">9</bibl> <bibtext> Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr. Probl. Cancer. 2018; 42: 457-465. 30064936. 10.1016/j.currproblcancer.2018.06.003</bibtext> </blist> <blist> <bibtext> Kobayashi O, Taguchi A, Nakajima T, Ikeda Y, Saito K, Kawana K. Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer. Taiwan J. Obstet. Gynecol. 2024; 63: 22-28. 38216264. 10.1016/j.tjog.2023.10.002</bibtext> </blist> <blist> <bibtext> Chauhan SR, Bharadwaj M. Gearing up T-cell immunotherapy in cervical cancer. Curr. Probl. Cancer. 2018; 42: 175-188. 29776594. 10.1016/j.currproblcancer.2018.04.001</bibtext> </blist> <blist> <bibtext> Alshami I, Alattas RO, Waad AA, Anwar AS. Role of T cells in cervical cancer. Bioinformation. 2023; 19: 556-561. 37886144. 10599678. 10.6026/97320630019556</bibtext> </blist> <blist> <bibtext> Sekula P, Del Greco MF, Pattaro C, Kottgen A. Mendelian randomization as an approach to assess causality using observational data. J. Am. Soc. Nephrol. 2016; 27: 3253-3265. 27486138. 5084898. 10.1681/ASN.2016010098</bibtext> </blist> <blist> <bibtext> Smith GD, Ebrahim S. Mendelian randomization: Prospects, potentials, and limitations. Int. J. Epidemiol. 2004; 33: 30-42. 15075143. 10.1093/ije/dyh132</bibtext> </blist> <blist> <bibtext> Kojima S, Kawana K, Tomio K, Yamashita A, Taguchi A, Miura S, Adachi K, Nagamatsu T, Nagasaka K, Matsumoto Y, Arimoto T, Oda K, Wada-Hiraike O, Yano T, Taketani Y, Fujii T, Schust DJ, Kozuma S. The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN. Am. J. Reprod. Immunol. 2013; 69: 134-141. 1:CAS:528:DC%2BC3sXjslKjurg%3D. 23057776. 10.1111/aji.12030</bibtext> </blist> <blist> <bibtext> Kawachi A, Yoshida H, Kitano S, Ino Y, Kato T, Hiraoka N. Tumor-associated CD204(+) M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma. Cancer Sci. 2018; 109: 863-870. 1:CAS:528:DC%2BC1cXitV2mtLo%3D. 29274107. 5834786. 10.1111/cas.13476</bibtext> </blist> <blist> <bibtext> Orru V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A, Virdis F, Piras MG, Lobina M, Marongiu M, Pitzalis M, Deidda F, Loizedda A, Onano S, Zoledziewska M, Sawcer S, Devoto M, Gorospe M, Abecasis GR, Floris M, Pala M, Schlessinger D, Fiorillo E, Cucca F. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat. Genet. 2020; 52: 1036-1045. 1:CAS:528:DC%2BB3cXhvVanu7zN. 32929287. 8517961. 10.1038/s41588-020-0684-4</bibtext> </blist> <blist> <bibtext> Wang C, Zhu D, Zhang D, Zuo X, Yao L, Liu T, Ge X, He C, Zhou Y, Shen Z. Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study. BMC Psychiatry. 2023; 23: 590. 37582716. 10428653. 10.1186/s12888-023-05081-4</bibtext> </blist> <blist> <bibtext> Sidore C, Busonero F, Maschio A, Porcu E, Naitza S, Zoledziewska M, Mulas A, Pistis G, Steri M, Danjou F, Kwong A, Ortega Del Vecchyo VD, Chiang CWK, Bragg-Gresham J, Pitzalis M, Nagaraja R, Tarrier B, Brennan C, Uzzau S, Fuchsberger C, Atzeni R, Reinier F, Berutti R, Huang J, Timpson NJ, Toniolo D, Gasparini P, Malerba G, Dedoussis G, Zeggini E, Soranzo N, Jones C, Lyons R, Angius A, Kang HM, Novembre J, Sanna S, Schlessinger D, Cucca F, Abecasis GR. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. 2015; 47: 1272-1281. 1:CAS:528:DC%2BC2MXhsV2lt7zM. 26366554. 4627508. 10.1038/ng.3368</bibtext> </blist> <blist> <bibtext> Orru V, Steri M, Sole G, Sidore C, Virdis F, Dei M, Lai S, Zoledziewska M, Busonero F, Mulas A, Floris M, Mentzen WI, Urru SA, Olla S, Marongiu M, Piras MG, Lobina M, Maschio A, Pitzalis M, Urru MF, Marcelli M, Cusano R, Deidda F, Serra V, Oppo M, Pilu R, Reinier F, Berutti R, Pireddu L, Zara I, Porcu E, Kwong A, Brennan C, Tarrier B, Lyons R, Kang HM, Uzzau S, Atzeni R, Valentini M, Firinu D, Leoni L, Rotta G, Naitza S, Angius A, Congia M, Whalen MB, Jones CM, Schlessinger D, Abecasis GR, Fiorillo E, Sanna S, Cucca F. Genetic variants regulating immune cell levels in health and disease. Cell. 2013; 155: 242-256. 1:CAS:528:DC%2BC3sXhsFemsrnM. 24074872. 5541764. 10.1016/j.cell.2013.08.041</bibtext> </blist> <blist> <bibtext> Genomes Project CAuton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR. A global reference for human genetic variation. Nature. 2015; 526: 68-74. 2015Natur.526.68T. 10.1038/nature15393</bibtext> </blist> <blist> <bibtext> Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 2015; 44: 512-525. 26050253. 4469799. 10.1093/ije/dyv080</bibtext> </blist> <blist> <bibtext> Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: Comparison of allele score and summarized data methods. Stat. Med. 2016; 35: 1880-1906. 3513491. 26661904. 10.1002/sim.6835</bibtext> </blist> <blist> <bibtext> Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat. Methods Med. Res. 2017; 26: 2333-2355. 3712236. 26282889. 10.1177/0962280215597579</bibtext> </blist> <blist> <bibtext> Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 2018; 50: 693-698. 1:CAS:528:DC%2BC1cXotF2kt7g%3D. 29686387. 6083837. 10.1038/s41588-018-0099-7</bibtext> </blist> <blist> <bibtext> Bai M, Sun R, Cao B, Feng J, Wang J. Monocyte-related cytokines/chemokines in cerebral ischemic stroke. CNS Neurosci. Ther. 2023; 29: 3693-3712. 1:CAS:528:DC%2BB3sXhsFyjurfF. 37452512. 10651979. 10.1111/cns.14368</bibtext> </blist> <blist> <bibtext> Shantsila E, Wrigley B, Tapp L, Apostolakis S, Montoro-Garcia S, Drayson MT, Lip GY. Immunophenotypic characterization of human monocyte subsets: Possible implications for cardiovascular disease pathophysiology. J. Thromb. Haemost. 2011; 9: 1056-1066. 1:CAS:528:DC%2BC3MXotFymtbk%3D. 21342432. 10.1111/j.1538-7836.2011.04244.x</bibtext> </blist> <blist> <bibtext> Damasceno D, Teodosio C, van den Bossche WBL, Perez-Andres M, Arriba-Mendez S, Munoz-Bellvis L, Romero A, Blanco JF, Remesal A, Puig N, Matarraz S, Vicente-Villardon JL, van Dongen JJM, Almeida J, Orfao ATiMaScan Study G. Distribution of subsets of blood monocytic cells throughout life. J. Allergy Clin. Immunol. 2019; 144: 320-323e326. 30890326. 10.1016/j.jaci.2019.02.030</bibtext> </blist> <blist> <bibtext> Cormican S, Griffin MD. Human monocyte subset distinctions and function: Insights from gene expression analysis. Front. Immunol. 2020; 11: 1070. 1:CAS:528:DC%2BB3cXitVWns7jM. 32582174. 7287163. 10.3389/fimmu.2020.01070</bibtext> </blist> <blist> <bibtext> Wu H, Gower RM, Wang H, Perrard XY, Ma R, Bullard DC, Burns AR, Paul A, Smith CW, Simon SI, Ballantyne CM. Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation. 2009; 119: 2708-2717. 1:CAS:528:DC%2BD1MXmtVGru7w%3D. 19433759. 2716173. 10.1161/CIRCULATIONAHA.108.823740</bibtext> </blist> <blist> <bibtext> Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010; 116: e74-80. 1:CAS:528:DC%2BC3cXhsVSku7jN. 20628149. 10.1182/blood-2010-02-258558</bibtext> </blist> <blist> <bibtext> Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, Senechal B, Puel A, Biswas SK, Moshous D, Picard C, Jais JP, D'Cruz D, Casanova JL, Trouillet C, Geissmann F. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity. 2010; 33: 375-386. 1:CAS:528:DC%2BC3cXht1SntLjP. 20832340. 3063338. 10.1016/j.immuni.2010.08.012</bibtext> </blist> <blist> <bibtext> Hijdra D, Vorselaars AD, Grutters JC, Claessen AM, Rijkers GT. Differential expression of TNFR1 (CD120a) and TNFR2 (CD120b) on subpopulations of human monocytes. J. Inflamm. (Lond). 2012; 9: 38. 1:CAS:528:DC%2BC3sXhs1yrsL8%3D. 23039818. 10.1186/1476-9255-9-38</bibtext> </blist> <blist> <bibtext> Beyer M, Mallmann MR, Xue J, Staratschek-Jox A, Vorholt D, Krebs W, Sommer D, Sander J, Mertens C, Nino-Castro A, Schmidt SV, Schultze JL. High-resolution transcriptome of human macrophages. PLoS One. 2012; 7. 2012PLoSO.745466B. 1:CAS:528:DC%2BC38XhsVaktbvN. 23029029. 3448669. 10.1371/journal.pone.0045466</bibtext> </blist> <blist> <bibtext> Williams H, Mack C, Baraz R, Marimuthu R, Naralashetty S, Li S, Medbury H. Monocyte differentiation and heterogeneity: inter-subset and interindividual differences. Int. J. Mol. Sci. 2023; 24: 8757. 1:CAS:528:DC%2BB3sXhtFemtLnM. 37240103. 10218702. 10.3390/ijms24108757</bibtext> </blist> <blist> <bibtext> Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001; 293: 2108-2111. 2001Sci.293.2108T. 1:CAS:528:DC%2BD3MXntVCitrg%3D. 11509692. 10.1126/science.1061965</bibtext> </blist> <blist> <bibtext> Darce JR, Arendt BK, Wu X, Jelinek DF. Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 2007; 179: 7276-7286. 1:CAS:528:DC%2BD2sXhtlajt7%2FN. 18025170. 10.4049/jimmunol.179.11.7276</bibtext> </blist> <blist> <bibtext> Caro-Maldonado A, Wang R, Nichols AG, Kuraoka M, Milasta S, Sun LD, Gavin AL, Abel ED, Kelsoe G, Green DR, Rathmell JC. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 2014; 192: 3626-3636. 1:CAS:528:DC%2BC2cXls1GmtL4%3D. 24616478. 10.4049/jimmunol.1302062</bibtext> </blist> <blist> <bibtext> Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 2019; 18: 197-218. 1:CAS:528:DC%2BC1MXlslKlsrw%3D. 30610226. 10.1038/s41573-018-0007-y</bibtext> </blist> <blist> <bibtext> Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017; 541: 321-330. 2017Natur.541.321C. 1:CAS:528:DC%2BC2sXht1Oksr8%3D. 28102259. 10.1038/nature21349</bibtext> </blist> <blist> <bibtext> Hegde PS, Karanikas V, Evers S. The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition. Clin. Cancer Res. 2016; 22: 1865-1874. 1:CAS:528:DC%2BC28XmsFeqs70%3D. 27084740. 10.1158/1078-0432.CCR-15-1507</bibtext> </blist> <blist> <bibtext> Liu YT, Sun ZJ. Turning cold tumors into hot tumors by improving T-cell infiltration. Theranostics. 2021; 11: 5365-5386. 1:CAS:528:DC%2BB3MXhsV2gtb3P. 33859752. 8039952. 10.7150/thno.58390</bibtext> </blist> <blist> <bibtext> Hegde PS, Chen DS. Top 10 challenges in cancer immunotherapy. Immunity. 2020; 52: 17-35. 1:CAS:528:DC%2BB3cXnslWksbo%3D. 31940268. 10.1016/j.immuni.2019.12.011</bibtext> </blist> </ref> <aug> <p>By Zicheng Zhao; Pengxian Yan; Xiaoyu Zhang; Xiaomin Yu; Fengchun Lv; Mingyu Gong and Xiu-An Yang</p> <p>Reported by Author; Author; Author; Author; Author; Author; Author</p> </aug> <nolink nlid="nl1" bibid="bib10" firstref="ref11"></nolink> <nolink nlid="nl2" bibid="bib11" firstref="ref12"></nolink> <nolink nlid="nl3" bibid="bib12" firstref="ref13"></nolink> <nolink nlid="nl4" bibid="bib13" firstref="ref14"></nolink> <nolink nlid="nl5" bibid="bib14" firstref="ref19"></nolink> <nolink nlid="nl6" bibid="bib15" firstref="ref20"></nolink> <nolink nlid="nl7" bibid="bib16" firstref="ref21"></nolink> <nolink nlid="nl8" bibid="bib17" firstref="ref22"></nolink> <nolink nlid="nl9" bibid="bib18" firstref="ref23"></nolink> <nolink nlid="nl10" bibid="bib19" firstref="ref24"></nolink> <nolink nlid="nl11" bibid="bib20" firstref="ref26"></nolink> <nolink nlid="nl12" bibid="bib21" firstref="ref31"></nolink> <nolink nlid="nl13" bibid="bib22" firstref="ref32"></nolink> <nolink nlid="nl14" bibid="bib23" firstref="ref33"></nolink> <nolink nlid="nl15" bibid="bib24" firstref="ref34"></nolink> <nolink nlid="nl16" bibid="bib25" firstref="ref36"></nolink> <nolink nlid="nl17" bibid="bib26" firstref="ref39"></nolink> <nolink nlid="nl18" bibid="bib27" firstref="ref40"></nolink> <nolink nlid="nl19" bibid="bib28" firstref="ref41"></nolink> <nolink nlid="nl20" bibid="bib29" firstref="ref42"></nolink> <nolink nlid="nl21" bibid="bib30" firstref="ref43"></nolink> <nolink nlid="nl22" bibid="bib31" firstref="ref44"></nolink> <nolink nlid="nl23" bibid="bib32" firstref="ref45"></nolink> <nolink nlid="nl24" bibid="bib33" firstref="ref46"></nolink> <nolink nlid="nl25" bibid="bib34" firstref="ref47"></nolink> <nolink nlid="nl26" bibid="bib35" firstref="ref48"></nolink> <nolink nlid="nl27" bibid="bib36" firstref="ref49"></nolink> <nolink nlid="nl28" bibid="bib37" firstref="ref50"></nolink> <nolink nlid="nl29" bibid="bib38" firstref="ref51"></nolink> <nolink nlid="nl30" bibid="bib39" firstref="ref52"></nolink> <nolink nlid="nl31" bibid="bib40" firstref="ref53"></nolink> <nolink nlid="nl32" bibid="bib41" firstref="ref54"></nolink> <nolink nlid="nl33" bibid="bib42" firstref="ref55"></nolink> <nolink nlid="nl34" bibid="bib43" firstref="ref56"></nolink>
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=20452322&ISBN=&volume=14&issue=1&date=20240201&spage=1&pages=1-13&title=Scientific Reports&atitle=A%20pilot%20study%20of%20measuring%20emotional%20response%20and%20perception%20of%20LLM-generated%20questionnaire%20and%20human-generated%20questionnaires&aulast=Zhao%20Zou&id=DOI:10.1038/s41598-024-53255-1
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/d4518c76740446ccb484f76a34505db3
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.4518c76740446ccb484f76a34505db3
RelevancyScore: 1020
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1020.39056396484
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A pilot study of measuring emotional response and perception of LLM-generated questionnaire and human-generated questionnaires
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zhao+Zou%22">Zhao Zou</searchLink><br /><searchLink fieldCode="AR" term="%22Omar+Mubin%22">Omar Mubin</searchLink><br /><searchLink fieldCode="AR" term="%22Fady+Alnajjar%22">Fady Alnajjar</searchLink><br /><searchLink fieldCode="AR" term="%22Luqman+Ali%22">Luqman Ali</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Nature Portfolio, 2024.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2024
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Medicine<br />LCC:Science
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Science%22">Science</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Abstract The advent of ChatGPT has sparked a heated debate surrounding natural language processing technology and AI-powered chatbots, leading to extensive research and applications across various disciplines. This pilot study aims to investigate the impact of ChatGPT on users' experiences by administering two distinct questionnaires, one generated by humans and the other by ChatGPT, along with an Emotion Detecting Model. A total of 14 participants (7 female and 7 male) aged between 18 and 35 years were recruited, resulting in the collection of 8672 ChatGPT-associated data points and 8797 human-associated data points. Data analysis was conducted using Analysis of Variance (ANOVA). The results indicate that the utilization of ChatGPT enhances participants' happiness levels and reduces their sadness levels. While no significant gender influences were observed, variations were found about specific emotions. It is important to note that the limited sample size, narrow age range, and potential cultural impacts restrict the generalizability of the findings to a broader population. Future research directions should explore the impact of incorporating additional language models or chatbots on user emotions, particularly among specific age groups such as older individuals and teenagers. As one of the pioneering works evaluating the human perception of ChatGPT text and communication, it is noteworthy that ChatGPT received positive evaluations and demonstrated effectiveness in generating extensive questionnaires.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2045-2322
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://doaj.org/toc/2045-2322
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1038/s41598-024-53255-1
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/d4518c76740446ccb484f76a34505db3" linkWindow="_blank">https://doaj.org/article/d4518c76740446ccb484f76a34505db3</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.4518c76740446ccb484f76a34505db3
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4518c76740446ccb484f76a34505db3
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-024-53255-1
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 1
    Subjects:
      – SubjectFull: Medicine
        Type: general
      – SubjectFull: Science
        Type: general
    Titles:
      – TitleFull: A pilot study of measuring emotional response and perception of LLM-generated questionnaire and human-generated questionnaires
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhao Zou
      – PersonEntity:
          Name:
            NameFull: Omar Mubin
      – PersonEntity:
          Name:
            NameFull: Fady Alnajjar
      – PersonEntity:
          Name:
            NameFull: Luqman Ali
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20452322
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific Reports
              Type: main
ResultId 1